New selenium nanohybrids for targeted doxorubicin delivery: Gamma-irradiation synthesis, controlled release and enhanced anticancer activity
Results in Engineering · 2026-12 · 32 · 112941
DOI: 10.1016/j.rineng.2026.112941 ↗Kurz gefasst
Fachartikel in der Zeitschrift Results in Engineering, 2026-12. Verfasst von Sakchai Laksee und 6 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Council of Thailand, Thailand Institute of Nuclear Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Research Council of Thailand
- Thailand Institute of Nuclear Technology
Zitieren
APA
Laksee, S., Charunrochana, P. T., Ngamkham, R., Punthama, P., Lertsarawut, P., Rattanawongwiboon, T., & Hemvichian, K. (2026). New selenium nanohybrids for targeted doxorubicin delivery: Gamma-irradiation synthesis, controlled release and enhanced anticancer activity. Results in Engineering, 32, 112941. https://doi.org/10.1016/j.rineng.2026.112941
Vancouver
Laksee S, Charunrochana PT, Ngamkham R, Punthama P, Lertsarawut P, Rattanawongwiboon T, et al. New selenium nanohybrids for targeted doxorubicin delivery: Gamma-irradiation synthesis, controlled release and enhanced anticancer activity. Results in Engineering. 2026;32:112941. doi:10.1016/j.rineng.2026.112941
BibTeX
@article{Laksee2026,
author = {Laksee, Sakchai and Charunrochana, Panupong Thammachoti and Ngamkham, Ratchanika and Punthama, Phinyapak and Lertsarawut, Pattra and Rattanawongwiboon, Thitirat and Hemvichian, Kasinee},
title = {New selenium nanohybrids for targeted doxorubicin delivery: Gamma-irradiation synthesis, controlled release and enhanced anticancer activity},
journal = {Results in Engineering},
year = {2026},
volume = {32},
pages = {112941},
doi = {10.1016/j.rineng.2026.112941}
}
EUVIMED